Moderna Some Approvals Ahead: Is the Stock a Buy?
Moderna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
The debate between points and cash back is ongoing. Understand the benefits of each to determine which suits you best.
28,655 articlesModerna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
A sharp price drop followed by a sizable insider sale can mean many things. This guide walks through what to watch in...
Bitcoin is testing a critical resistance near $70,000 as volatility persists. Analysts say a confirmed move above thi...
Bitcoin rebounded from a sub-$62,000 dip while Pi Network’s PI slumped to new lows. The split move underscores ongoin...
A Dallas-area restaurant owner says geopolitical tensions are pushing up costs and disrupting deliveries, squeezing m...
Pay transparency is surfacing a bigger problem: firms publish pay ranges but struggle to explain how they set actual ...
A major fiduciary manager disclosed a sizable purchase in the Vanguard Long-Term Corporate Bond ETF, signaling a stra...
A single viral moment can ripple through markets and your wallet. This guide explains how media buzz affects money de...
Lamborghini posts record 2025 deliveries but trims profits as it shelves its all electric Lanzador. The luxury maker ...
Sam Altman cautions that some companies are blaming AI for layoffs that were planned for other reasons, a trend with ...
Brent crude sits near $72.68 a barrel on July 1, 2026, as traders weigh demand trends and ongoing supply discipline. ...
Amazon lays out a multi-year AI and infrastructure push with a roughly $200 billion capex plan for 2026. Investors we...